US Patent Issued to Takeda Pharmaceutical on April 22 for "Substituted piperidine compound and use thereof" (Japanese Inventors)

ALEXANDRIA, Va., June 6 -- United States Patent no. 12,281,073, issued on April 22, was assigned to Takeda Pharmaceutical Co. Ltd. (Osaka, Japan).

"Substituted piperidine compound and use thereof" was invented by Tatsuhiko Fujimoto (Fujisawa, Japan), Kentaro Rikimaru (Fujisawa, Japan), Koichiro Fukuda (Fujisawa, Japan), Hiromichi Sugimoto (Tokyo), Takahiro Matsumoto (Fujisawa, Japan), Norihito Tokunaga (Fujisawa, Japan) and Mariko Hirozane (Fujisawa, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a substituted piperidine compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I):wherein each symbol is as described in the DESCRIPTION, or a salt ther...